Compile Data Set for Download or QSAR
Report error Found 107 Enz. Inhib. hit(s) with all data for entry = 11381
TargetApelin(Human)
Sanford Burnham Prebys Medical Discovery Institute

US Patent
LigandPNGBDBM610888(US10626096, Example 1 | 4-(2,6-Dimethoxyphenyl)-5-...)
Affinity DataEC50:  31nMAssay Description:The apelin receptor agonist activity of the compound represented by formula (I) or (II) of the present invention was measured by cell-based assay for...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/8/2023
Entry Details
Go to US Patent

TargetApelin(Human)
Sanford Burnham Prebys Medical Discovery Institute

US Patent
LigandPNGBDBM610889(US10626096, Example 2 | 2-({[4-(2,6-Dimethoxypheny...)
Affinity DataEC50:  1nMAssay Description:The apelin receptor agonist activity of the compound represented by formula (I) or (II) of the present invention was measured by cell-based assay for...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/8/2023
Entry Details
Go to US Patent

TargetApelin(Human)
Sanford Burnham Prebys Medical Discovery Institute

US Patent
LigandPNGBDBM610890(US10626096, Example 3 | 7-Chloro-2-({[4-(2,6-dimet...)
Affinity DataEC50:  2nMAssay Description:The apelin receptor agonist activity of the compound represented by formula (I) or (II) of the present invention was measured by cell-based assay for...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/8/2023
Entry Details
Go to US Patent

TargetApelin(Human)
Sanford Burnham Prebys Medical Discovery Institute

US Patent
LigandPNGBDBM610891(US10626096, Example 4 | Ethyl {[4-(2,6-dimethoxyph...)
Affinity DataEC50:  122nMAssay Description:The apelin receptor agonist activity of the compound represented by formula (I) or (II) of the present invention was measured by cell-based assay for...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/8/2023
Entry Details
Go to US Patent

TargetApelin(Human)
Sanford Burnham Prebys Medical Discovery Institute

US Patent
LigandPNGBDBM610892(US10626096, Example 5 | {[4-(2,6-Dimethoxyphenyl)-...)
Affinity DataEC50:  26nMAssay Description:The apelin receptor agonist activity of the compound represented by formula (I) or (II) of the present invention was measured by cell-based assay for...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/8/2023
Entry Details
Go to US Patent

TargetApelin(Human)
Sanford Burnham Prebys Medical Discovery Institute

US Patent
LigandPNGBDBM610893(US10626096, Example 6 | 4-(2,6-Dimethoxyphenyl)-3-...)
Affinity DataEC50:  703nMAssay Description:The apelin receptor agonist activity of the compound represented by formula (I) or (II) of the present invention was measured by cell-based assay for...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/8/2023
Entry Details
Go to US Patent

TargetApelin(Human)
Sanford Burnham Prebys Medical Discovery Institute

US Patent
LigandPNGBDBM610894(US10626096, Example 7 | [4-(2,6-Dimethoxyphenyl)-5...)
Affinity DataEC50:  815nMAssay Description:The apelin receptor agonist activity of the compound represented by formula (I) or (II) of the present invention was measured by cell-based assay for...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/8/2023
Entry Details
Go to US Patent

TargetApelin(Human)
Sanford Burnham Prebys Medical Discovery Institute

US Patent
LigandPNGBDBM610895(US10626096, Example 8)
Affinity DataEC50:  1.57E+3nMAssay Description:The apelin receptor agonist activity of the compound represented by formula (I) or (II) of the present invention was measured by cell-based assay for...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/8/2023
Entry Details
Go to US Patent

TargetApelin(Human)
Sanford Burnham Prebys Medical Discovery Institute

US Patent
LigandPNGBDBM610896(US10626096, Example 9 | (2E)-3-[4-(2,6-Dimethoxyph...)
Affinity DataEC50:  18nMAssay Description:The apelin receptor agonist activity of the compound represented by formula (I) or (II) of the present invention was measured by cell-based assay for...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/8/2023
Entry Details
Go to US Patent

TargetApelin(Human)
Sanford Burnham Prebys Medical Discovery Institute

US Patent
LigandPNGBDBM610897(US10626096, Example 10)
Affinity DataEC50:  192nMAssay Description:The apelin receptor agonist activity of the compound represented by formula (I) or (II) of the present invention was measured by cell-based assay for...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/8/2023
Entry Details
Go to US Patent

TargetApelin(Human)
Sanford Burnham Prebys Medical Discovery Institute

US Patent
LigandPNGBDBM610898(US10626096, Example 11 | [2-({[4-(2,6-Dimethoxyphe...)
Affinity DataEC50:  5nMAssay Description:The apelin receptor agonist activity of the compound represented by formula (I) or (II) of the present invention was measured by cell-based assay for...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/8/2023
Entry Details
Go to US Patent

TargetApelin(Human)
Sanford Burnham Prebys Medical Discovery Institute

US Patent
LigandPNGBDBM610899(US10626096, Example 12 | Ethyl 3-[4-(2,6-dimethoxy...)
Affinity DataEC50:  701nMAssay Description:The apelin receptor agonist activity of the compound represented by formula (I) or (II) of the present invention was measured by cell-based assay for...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/8/2023
Entry Details
Go to US Patent

TargetApelin(Human)
Sanford Burnham Prebys Medical Discovery Institute

US Patent
LigandPNGBDBM610900(US10626096, Example 13 | 3-[4-(2,6-Dimethoxyphenyl...)
Affinity DataEC50:  159nMAssay Description:The apelin receptor agonist activity of the compound represented by formula (I) or (II) of the present invention was measured by cell-based assay for...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/8/2023
Entry Details
Go to US Patent

TargetApelin(Human)
Sanford Burnham Prebys Medical Discovery Institute

US Patent
LigandPNGBDBM610901(US10626096, Example 14 | 6-({[4-(2,6-Dimethoxyphen...)
Affinity DataEC50:  424nMAssay Description:The apelin receptor agonist activity of the compound represented by formula (I) or (II) of the present invention was measured by cell-based assay for...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/8/2023
Entry Details
Go to US Patent

TargetApelin(Human)
Sanford Burnham Prebys Medical Discovery Institute

US Patent
LigandPNGBDBM610902(US10626096, Example 15 | 6-({[4-(2,6-Dimethoxyphen...)
Affinity DataEC50:  164nMAssay Description:The apelin receptor agonist activity of the compound represented by formula (I) or (II) of the present invention was measured by cell-based assay for...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/8/2023
Entry Details
Go to US Patent

TargetApelin(Human)
Sanford Burnham Prebys Medical Discovery Institute

US Patent
LigandPNGBDBM610903(US10626096, Example 16 | 5-({[4-(2,6-Dimethoxyphen...)
Affinity DataEC50:  314nMAssay Description:The apelin receptor agonist activity of the compound represented by formula (I) or (II) of the present invention was measured by cell-based assay for...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/8/2023
Entry Details
Go to US Patent

TargetApelin(Human)
Sanford Burnham Prebys Medical Discovery Institute

US Patent
LigandPNGBDBM610904(US10626096, Example 17)
Affinity DataEC50:  1.41E+3nMAssay Description:The apelin receptor agonist activity of the compound represented by formula (I) or (II) of the present invention was measured by cell-based assay for...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/8/2023
Entry Details
Go to US Patent

TargetApelin(Human)
Sanford Burnham Prebys Medical Discovery Institute

US Patent
LigandPNGBDBM610905(US10626096, Example 18 | 4-({[4-(2,6-Dimethoxyphen...)
Affinity DataEC50:  561nMAssay Description:The apelin receptor agonist activity of the compound represented by formula (I) or (II) of the present invention was measured by cell-based assay for...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/8/2023
Entry Details
Go to US Patent

TargetApelin(Human)
Sanford Burnham Prebys Medical Discovery Institute

US Patent
LigandPNGBDBM610906(US10626096, Example 19 | (2E)-3-[4-(2,6-Dimethoxyp...)
Affinity DataEC50:  171nMAssay Description:The apelin receptor agonist activity of the compound represented by formula (I) or (II) of the present invention was measured by cell-based assay for...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/8/2023
Entry Details
Go to US Patent

TargetApelin(Human)
Sanford Burnham Prebys Medical Discovery Institute

US Patent
LigandPNGBDBM610907(US10626096, Example 20 | (3E)-4-[4-(2,6-Dimethoxyp...)
Affinity DataEC50:  729nMAssay Description:The apelin receptor agonist activity of the compound represented by formula (I) or (II) of the present invention was measured by cell-based assay for...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/8/2023
Entry Details
Go to US Patent

TargetApelin(Human)
Sanford Burnham Prebys Medical Discovery Institute

US Patent
LigandPNGBDBM610908(US10626096, Example 21 | (2E)-3-[4-(2,6-Dimethoxyp...)
Affinity DataEC50:  539nMAssay Description:The apelin receptor agonist activity of the compound represented by formula (I) or (II) of the present invention was measured by cell-based assay for...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/8/2023
Entry Details
Go to US Patent

TargetApelin(Human)
Sanford Burnham Prebys Medical Discovery Institute

US Patent
LigandPNGBDBM610909(US10626096, Example 22)
Affinity DataEC50:  87nMAssay Description:The apelin receptor agonist activity of the compound represented by formula (I) or (II) of the present invention was measured by cell-based assay for...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/8/2023
Entry Details
Go to US Patent

TargetApelin(Human)
Sanford Burnham Prebys Medical Discovery Institute

US Patent
LigandPNGBDBM610910(US10626096, Example 23 | (3E)-4-[4-(2,6-Dimethoxyp...)
Affinity DataEC50:  271nMAssay Description:The apelin receptor agonist activity of the compound represented by formula (I) or (II) of the present invention was measured by cell-based assay for...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/8/2023
Entry Details
Go to US Patent

TargetApelin(Human)
Sanford Burnham Prebys Medical Discovery Institute

US Patent
LigandPNGBDBM610911(US10626096, Example 24 | 4-[4-(2,6-Dimethoxyphenyl...)
Affinity DataEC50:  751nMAssay Description:The apelin receptor agonist activity of the compound represented by formula (I) or (II) of the present invention was measured by cell-based assay for...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/8/2023
Entry Details
Go to US Patent

TargetApelin(Human)
Sanford Burnham Prebys Medical Discovery Institute

US Patent
LigandPNGBDBM610912(US10626096, Example 25 | 4-[4-(2,6-Dimethoxyphenyl...)
Affinity DataEC50:  1.72E+3nMAssay Description:The apelin receptor agonist activity of the compound represented by formula (I) or (II) of the present invention was measured by cell-based assay for...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/8/2023
Entry Details
Go to US Patent

TargetApelin(Human)
Sanford Burnham Prebys Medical Discovery Institute

US Patent
LigandPNGBDBM610913(US10626096, Example 26)
Affinity DataEC50:  57nMAssay Description:The apelin receptor agonist activity of the compound represented by formula (I) or (II) of the present invention was measured by cell-based assay for...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/8/2023
Entry Details
Go to US Patent

TargetApelin(Human)
Sanford Burnham Prebys Medical Discovery Institute

US Patent
LigandPNGBDBM610914(US10626096, Example 27)
Affinity DataEC50:  2.87E+3nMAssay Description:The apelin receptor agonist activity of the compound represented by formula (I) or (II) of the present invention was measured by cell-based assay for...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/8/2023
Entry Details
Go to US Patent

TargetApelin(Human)
Sanford Burnham Prebys Medical Discovery Institute

US Patent
LigandPNGBDBM610915(US10626096, Example 28)
Affinity DataEC50:  1.42E+3nMAssay Description:The apelin receptor agonist activity of the compound represented by formula (I) or (II) of the present invention was measured by cell-based assay for...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/8/2023
Entry Details
Go to US Patent

TargetApelin(Human)
Sanford Burnham Prebys Medical Discovery Institute

US Patent
LigandPNGBDBM610916(US10626096, Example 29)
Affinity DataEC50:  812nMAssay Description:The apelin receptor agonist activity of the compound represented by formula (I) or (II) of the present invention was measured by cell-based assay for...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/8/2023
Entry Details
Go to US Patent

TargetApelin(Human)
Sanford Burnham Prebys Medical Discovery Institute

US Patent
LigandPNGBDBM610917(US10626096, Example 30)
Affinity DataEC50:  332nMAssay Description:The apelin receptor agonist activity of the compound represented by formula (I) or (II) of the present invention was measured by cell-based assay for...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/8/2023
Entry Details
Go to US Patent

TargetApelin(Human)
Sanford Burnham Prebys Medical Discovery Institute

US Patent
LigandPNGBDBM610918(US10626096, Example 31)
Affinity DataEC50:  174nMAssay Description:The apelin receptor agonist activity of the compound represented by formula (I) or (II) of the present invention was measured by cell-based assay for...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/8/2023
Entry Details
Go to US Patent

TargetApelin(Human)
Sanford Burnham Prebys Medical Discovery Institute

US Patent
LigandPNGBDBM610919(US10626096, Example 32)
Affinity DataEC50:  3.98E+3nMAssay Description:The apelin receptor agonist activity of the compound represented by formula (I) or (II) of the present invention was measured by cell-based assay for...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/8/2023
Entry Details
Go to US Patent

TargetApelin(Human)
Sanford Burnham Prebys Medical Discovery Institute

US Patent
LigandPNGBDBM610920(US10626096, Example 33)
Affinity DataEC50:  2.44E+3nMAssay Description:The apelin receptor agonist activity of the compound represented by formula (I) or (II) of the present invention was measured by cell-based assay for...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/8/2023
Entry Details
Go to US Patent

TargetApelin(Human)
Sanford Burnham Prebys Medical Discovery Institute

US Patent
LigandPNGBDBM610921(US10626096, Example 34)
Affinity DataEC50:  152nMAssay Description:The apelin receptor agonist activity of the compound represented by formula (I) or (II) of the present invention was measured by cell-based assay for...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/8/2023
Entry Details
Go to US Patent

TargetApelin(Human)
Sanford Burnham Prebys Medical Discovery Institute

US Patent
LigandPNGBDBM610922(US10626096, Example 35)
Affinity DataEC50:  10nMAssay Description:The apelin receptor agonist activity of the compound represented by formula (I) or (II) of the present invention was measured by cell-based assay for...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/8/2023
Entry Details
Go to US Patent

TargetApelin(Human)
Sanford Burnham Prebys Medical Discovery Institute

US Patent
LigandPNGBDBM610923(US10626096, Example 36)
Affinity DataEC50:  108nMAssay Description:The apelin receptor agonist activity of the compound represented by formula (I) or (II) of the present invention was measured by cell-based assay for...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/8/2023
Entry Details
Go to US Patent

TargetApelin(Human)
Sanford Burnham Prebys Medical Discovery Institute

US Patent
LigandPNGBDBM610924(US10626096, Example 37 | Methyl {[4-(2,6-dimethoxy...)
Affinity DataEC50:  825nMAssay Description:The apelin receptor agonist activity of the compound represented by formula (I) or (II) of the present invention was measured by cell-based assay for...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/8/2023
Entry Details
Go to US Patent

TargetApelin(Human)
Sanford Burnham Prebys Medical Discovery Institute

US Patent
LigandPNGBDBM610925(US10626096, Example 38 | {[4-(2,6-Dimethoxyphenyl)...)
Affinity DataEC50:  9nMAssay Description:The apelin receptor agonist activity of the compound represented by formula (I) or (II) of the present invention was measured by cell-based assay for...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/8/2023
Entry Details
Go to US Patent

TargetApelin(Human)
Sanford Burnham Prebys Medical Discovery Institute

US Patent
LigandPNGBDBM610926(US10626096, Example 39)
Affinity DataEC50:  11nMAssay Description:The apelin receptor agonist activity of the compound represented by formula (I) or (II) of the present invention was measured by cell-based assay for...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/8/2023
Entry Details
Go to US Patent

TargetApelin(Human)
Sanford Burnham Prebys Medical Discovery Institute

US Patent
LigandPNGBDBM610927(US10626096, Example 40 | 3-(Benzylsulfanyl)-4-(2,6...)
Affinity DataEC50:  1.11E+3nMAssay Description:The apelin receptor agonist activity of the compound represented by formula (I) or (II) of the present invention was measured by cell-based assay for...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/8/2023
Entry Details
Go to US Patent

TargetApelin(Human)
Sanford Burnham Prebys Medical Discovery Institute

US Patent
LigandPNGBDBM610928(US10626096, Example 41)
Affinity DataEC50:  45nMAssay Description:The apelin receptor agonist activity of the compound represented by formula (I) or (II) of the present invention was measured by cell-based assay for...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/8/2023
Entry Details
Go to US Patent

TargetApelin(Human)
Sanford Burnham Prebys Medical Discovery Institute

US Patent
LigandPNGBDBM610929(US10626096, Example 42)
Affinity DataEC50:  12nMAssay Description:The apelin receptor agonist activity of the compound represented by formula (I) or (II) of the present invention was measured by cell-based assay for...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/8/2023
Entry Details
Go to US Patent

TargetApelin(Human)
Sanford Burnham Prebys Medical Discovery Institute

US Patent
LigandPNGBDBM610930(US10626096, Example 43)
Affinity DataEC50:  39nMAssay Description:The apelin receptor agonist activity of the compound represented by formula (I) or (II) of the present invention was measured by cell-based assay for...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/8/2023
Entry Details
Go to US Patent

TargetApelin(Human)
Sanford Burnham Prebys Medical Discovery Institute

US Patent
LigandPNGBDBM610931(US10626096, Example 44 | 3-Bromo-4-(2,6-dimethoxyp...)
Affinity DataEC50:  1.21E+3nMAssay Description:The apelin receptor agonist activity of the compound represented by formula (I) or (II) of the present invention was measured by cell-based assay for...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/8/2023
Entry Details
Go to US Patent

TargetApelin(Human)
Sanford Burnham Prebys Medical Discovery Institute

US Patent
LigandPNGBDBM610932(US10626096, Example 45 | Methyl 3-[4-(2,6-dimethox...)
Affinity DataEC50:  1.32E+3nMAssay Description:The apelin receptor agonist activity of the compound represented by formula (I) or (II) of the present invention was measured by cell-based assay for...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/8/2023
Entry Details
Go to US Patent

TargetApelin(Human)
Sanford Burnham Prebys Medical Discovery Institute

US Patent
LigandPNGBDBM610933(US10626096, Example 46 | 3-[4-(2,6-Dimethoxyphenyl...)
Affinity DataEC50:  96nMAssay Description:The apelin receptor agonist activity of the compound represented by formula (I) or (II) of the present invention was measured by cell-based assay for...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/8/2023
Entry Details
Go to US Patent

TargetApelin(Human)
Sanford Burnham Prebys Medical Discovery Institute

US Patent
LigandPNGBDBM610934(US10626096, Example 47 | Methyl 4-[4-(2,6-dimethox...)
Affinity DataEC50:  419nMAssay Description:The apelin receptor agonist activity of the compound represented by formula (I) or (II) of the present invention was measured by cell-based assay for...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/8/2023
Entry Details
Go to US Patent

TargetApelin(Human)
Sanford Burnham Prebys Medical Discovery Institute

US Patent
LigandPNGBDBM610935(US10626096, Example 48 | 4-[4-(2,6-Dimethoxyphenyl...)
Affinity DataEC50:  22nMAssay Description:The apelin receptor agonist activity of the compound represented by formula (I) or (II) of the present invention was measured by cell-based assay for...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/8/2023
Entry Details
Go to US Patent

TargetApelin(Human)
Sanford Burnham Prebys Medical Discovery Institute

US Patent
LigandPNGBDBM610936(US10626096, Example 49)
Affinity DataEC50:  393nMAssay Description:The apelin receptor agonist activity of the compound represented by formula (I) or (II) of the present invention was measured by cell-based assay for...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/8/2023
Entry Details
Go to US Patent

TargetApelin(Human)
Sanford Burnham Prebys Medical Discovery Institute

US Patent
LigandPNGBDBM610937(US10626096, Example 50)
Affinity DataEC50:  1.32E+3nMAssay Description:The apelin receptor agonist activity of the compound represented by formula (I) or (II) of the present invention was measured by cell-based assay for...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/8/2023
Entry Details
Go to US Patent

Displayed 1 to 50 (of 107 total ) | Next | Last >>
Jump to: